Multitarget flourescence in situ hybridization elucidates equivocal lung cytology

Chest

Volumn 129, Issue 6, 2006, Pages 1629-1635

  Savic, Spasenija ^a   Glatz, Katharina ^a   Schoenegg, René ^c   Spieler, Peter ^c   Feichter, Georg ^a   Tamm, Michael ^b   Bubendorf, Lukas ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Cytology; Equivocal; Fluorescence in situ hybridization; Lung cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTICOAGULATION; ARTICLE; BENIGN TUMOR; BRACHYTHERAPY; BRONCHITIS; CANCER CYTODIAGNOSIS; CARCINOMA IN SITU; CHROMOSOME 5P; CHROMOSOME 6; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYTOPATHOLOGY; EPIFLUORESCENCE MICROSCOPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG INFILTRATE; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUBERCULOSIS; MALE; MANTLE CELL LYMPHOMA; ONCOGENE MYC; ORGANIZING PNEUMONIA; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADOLESCENT; CARCINOMA; DIFFERENTIAL DIAGNOSIS; GENETICS; LUNG DISEASE; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROTO ONCOGENE; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENES, ERBB-1; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 33745170410     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.6.1629     Document Type: Article

References (32)

1. Ferlay J, Bray F, Parkin DM, et al. Globocan 2000: Cancer incidence and mortality worldwide. IARC Cancer Bases No. 5. Lyon, France: IARC Press, 2001
2. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003; 123:115S-128S
3. Steffee CH, Segletes LA, Geisinger KR. Changing cytologic and histologic utilization patterns in the diagnosis of 515 primary lung malignancies. Cancer 1997; 81:105-115
4. Jones AM, Hanson IM, Armstrong GR, et al. Value and accuracy of cytology in addition to histology in the diagnosis of lung cancer at flexible bronchoscopy. Respir Med 2001; 95:374-378
5. Crapanzano JP, Zakowski MF. Diagnostic dilemmas in pulmonary cytology. Cancer 2001; 93:364-375
6. Linder J. Errors and pitfalls in lung and pleural cytology. Monogr Pathol 1997; 40-59
7. DeMay RM. The art and science of cytopathology. Chicago, IL: ASCP Press, 1996
8. Silverman JF. Inflammatory and neoplastic processes of the lung: differential diagnosis and pitfalls in FNA biopsies. Diagn Cytopathol 1995; 13:448-462
9. Naryshkin S, Young NA. Respiratory cytology: a review of non-neoplastic mimics of malignancy. Diagn Cytopathol 1993; 9:89-97
10. Johnston WW. Type II pneumocytes in cytologic specimens: a diagnostic dilemma. Am J Clin Pathol 1992; 97:608-609
11. Grotte D, Stanley MW, Swanson PE, et al. Reactive type II pneumocytes in bronchoalveolar lavage fluid from adult respiratory distress syndrome can be mistaken for cells of adenocarcinoma. Diagn Cytopathol 1990; 6:317-322
12. Knuutila S, Aalto Y, Autio K, et al. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155:683-694
13. Testa JR, Liu Z, Feder M, et al. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 1997; 95:20-32
14. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 1997; 57:2331-2335
15. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002; 21:6877-6883
16. Albertson DG, Collins C, McCormick F, et al. Chromosome aberrations in solid tumors. Nat Genet 2003; 34:369-376
17. Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol 2002; 11:47-57
18. Halling KC. Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn 2003; 3:507-519
19. Bubendorf L, Grilli B, Sauter G, et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001; 116:79-86
20. Bubendorf L, Grilli B. UroVysion multiprobe FISH in urinary cytology. Methods Mol Med 2004; 97:117-131
21. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer 2002; 96:306-315
22. Bubendorf L, Muller P, Joos L, et al. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 2005; 123:516-523
23. Romeo MS, Sokolova IA, Morrison LE, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn 2003; 5:103-112
24. Nakamura H, Aute I, Kawasaki N, et al. Quantitative detection of lung cancer cells by fluorescence in situ hybridization: comparison with conventional cytology. Chest 2005; 128:906-911
25. Yoneda K, Boucher LD. Bronchial epithelial changes associated with small cell carcinoma of the lung. Hum Pathol 1993; 24:1180-1183
26. Kayser K, Hagemeyer O, Runtsch T. Morphologic lesions in non-neoplastic bronchial mucosa associated with bronchial carcinomas [in German]. Zentralbl Pathol 1991; 137:425-429
27. Whang-Peng J, Bunn PA Jr, Kao-Shan CS, et al. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet 1982; 6:119-134
28. Ried T, Petersen I, Holtgreve-Grez H, et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 1994; 54:1801-1806
29. Salomon DS, Gullick WJ. Perspectives on the EGF family and the mammary gland. J Mammary Gland Biol Neoplasia 1997; 2:199
30. Bubendorf L, Kononen J, Koivisto P, et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res 1999; 59:803-806
31. Obara K, Yokoyama M, Asano G, et al. Evaluation of myc and chromosome 8 copy number in colorectal cancer using interphase cytogenetics. Int J Oncol 2001; 18:233-239
32. Holzmann K, Kohlhammer H, Schwaenen C, et al. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Res 2004; 64:4428-4433